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Treatment Costs for the Patient
with Head and Neck Tumours
Summary
Surgery of head and neck tumours is complex and unequivocally
expensive. There have been very few investigations to date in the world
on the cost of treatment of this group of patients, and in Croatia not
one. The aim of the present study was to determine the cost of treating
patients with head and neck tumours, its structure and factors which
have a significant influence on it. The study included 248 patients, treat-
ed in the Clinic of Maxillofacial Surgery in Zagreb during the period
1995 - 1996. The cost of treatment is presented as the total cost of hospi-
tal expenses, diagnostics, operations, anaesthesia and radiotherapy,
and its dependence on all factors tested which we assumed to have a
significant effect on it.
The average cost of treatment for the patient with head and neck
tumours is 17,297 kn. The duration of hospitalisation, type of ablation
and reconstructive surgical procedure has the greatest influence on the
cost of treatment. Thus, intervention in this segment would enable the
greatest savings. As the duration of treatment and type of therapy is
decided by the physician, the planning and realisation of cheaper treat-
ment is the responsibility of the physician.









2Clinic of Maxillofacial and
Oral Surgery, University
Hospital Dubrava, Zagreb
3Department of Oral Surgery












Tel: +387 63 312 439
e-mail: juricdr@cob.net.ba
Introduction
The costs of health care in the world have steadi-
ly increased over the last ten years. Health costs
not only burden the national economies of undevel-
oped countries but also of the most developed coun-
tries in the world (1, 2). Attempts have been made
to control further, uncontrolled increases in the cost
of health care by the introduction of national pro-
grammes (3).
In the Republic of Croatia, after several decades
of systematic stimulation of spending health resources,
the time has come when available means are restrict-
ed and within which health care must be planned (4).
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The treatment of the patient with head and neck
tumours is complex and long-term. Few investiga-
tions have been conducted on the cost of treating
patients with head and neck tumours (5), and in the
Republic of Croatia no such study has been carried
out to date.
The aim of this study was to determine the cost
of treating patients with head and neck tumours, its
structure and factors which have a significant effect
on it, and which are connected with certain charac-
teristics of the patient, disease and therapeutic process,
and to discover a reserve, whose redirection would
enable the achievement of saving.
Patients and methods
The investigation included patients with head and
neck tumours, treated in the Clinic of Maxillofa-
cial and Oral Surgery, University Hospital Dubra-
va in Zagreb, from 10 April 1995 until 10 October
1996. Nineteen patients were excluded from the
investigation who had started treatment after 10
April 1996, or had finished treatment after 10 Octo-
ber 1996, and patients with incomplete medical data.
For the remaining 248 patients data on the patient,
disease and therapeutic process were collected from
the hospital records, and the cost of treatment for all
patients was obtained from the hospital's accounts
department. For each patient the cost of treatment is
presented as the total cost: hospital accommoda-
tion and care, diagnostic tests/examinations, med-
ication therapy, operations, anaesthesia and radio-
therapy. Dependence of the cost of treatment and its
components was tested in relation to all factors
which we presumed to have a significant influence
on it, and which are connected with certain charac-
teristics of the patient, tumour or therapeutic process.
For statistical analysis, analysis of variance (ANOVA)
and multivariate regressive analysis were used. Tests
were performed with the level of statistical signifi-
cance of 0.05.
Results
The study included 248 patients with head and
neck tumours. The average age of the subjects was
52 years. Men three times more frequently suffered
from head and neck tumours than women. The most
frequent type of tumour was intraoral carcinoma and
carcinoma of the oropharynx (131 patients), and the
most frequent histopathological type tumour was
planocellular carcinoma (177 patients). Comman-
do operation was most frequently practised (71
patients), and local flap was most frequently used
for reconstruction of surgical defects (79 patients).
The average duration of treatment was 33 days, aver-
age preoperative stay 8 days and postoperative 21
days.
The average cost of treatment for the patient was
17,297.8 kn (SD 15,157.8 kn), and the average cost
of one day of hospital treatment 527 kn. The total
share of the cost of medication therapy and hospi-
tal accommodation was 78% (13,668.6 kn) and the
share of the cost of the operation and anaesthesia
14% (2,406.6 kn) Table 1). Because of non-sym-
metrical distribution of mean values and medians
the costs of treatment were computed with loga-
rithms. The obtained geometric means differ from
the non-transformed arithmetic means, although the
mutual relations of factors of the total costs were
retained.
Increased complexity of the ablation and recon-
structive operation significantly influenced the duration
of treatment and the total cost of treatment with p<0.01
for each of the aforementioned factors (Table 2).
The total cost of treatment showed 60% varia-
tion in the data (R2=0.60). Extended treatment
increased the total cost by coefficient 0.01 (p<0.01).
With this increase in the complexity of the ablation
operation the total cost of treatment increased by
coefficient 0.14 (p<0.01). Complex reconstructive
operations caused an increase in the total cost of
treatment, which increased by the coefficient 0.16
(p<0.01) (Table 3).
Discussion
The average cost of treatment for the patient in
this investigation was 17,297.8 Kn. The structure of
this cost in which the share of so-called hospital
costs were 78% is significant, which is almost twice
as high as the adopted standards, in which the
amount of hospital costs do not exceed 40% (6). The
cost of the operation and anaesthesia in this study
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amounted to only 14% of the total treatment costs,
compared to the usual approximate 40% share in the
world. Such a result is only partially a consequence
of the reduced influence of economic laws on the
cost of the operation and anaesthesia, and more the
consequence of long-term hospitalisation, which
most increases hospital costs.
The duration of treatment strongly effects the cost
of treatment (3) and intervention in this segment
could produce the greatest saving. The duration of
treatment is directly dependent on the type and com-
plexity of the ablation and reconstructive operation,
which is impossible to influence during the phase of
admittance to hospital. Reducing hospital treatment
can be achieved by reducing the waiting period for
the operation and reducing postoperative stay. Expe-
rience in the USA confirmed the possibility of real-
ising saving at the expense of reduced treatment.
Namely, following the introduction of Health Main-
tenance Organisations (HMO) (7) and Diagnosis
Related Groups (DRG) (3,8) the average duration
of treatment of the patient with head and neck
tumours was reduced from 16 to 10 days, and pre-
operative stay from 3 to 0.9 days (3). The possibil-
ity of reducing treatment in Croatia exists, and the
saving which could be achieved in this way is sig-
nificant, because the average cost of one day of hos-
pital treatment is 527 kn. It is possible to reduce pre-
operative stay by expeditious hospitalisation, out-
patient preoperative preparation and correction of
nutritional condition. The duration of the postoper-
ative stay is directly connected with the preopera-
tive condition of the patient, earlier diseases, type
and extent of the operation and local or general post-
operative complications. Experience in the USA
confirmed that reducing postoperative stay can be
achieved by coordinating activity of the therapeu-
tic teams, education of the patient in self-help, ear-
lier release into a hospital of lower rank and into
home care (3). Additional reduction of treatment to
an ideal 8 days is possible to achieve by introduc-
ing clinical therapeutic protocol (CCP) (9).
Treatment cost increases concurrently with the
complexity of the ablation procedure. Patients with
advanced local and regional disease require an
expensive, combined method of treatment, which
increases two-year survival by 30%, and five-year
survival by only 10% (10). After introducing Diag-
nosis Related Groups in the USA the number of
complex operational procedures was reduced from
22% to 15%, and the number of limited and mod-
erately complex operations increased from 18% to
28% (3). Such practice enables satisfactory moni-
toring prior to prophylactic dissection of the neck in
patients with initial disease and palliative operation
prior to combined surgical-radiotherapeutic proce-
dure in patients with advanced local and regional
disease. By introducing such practice in Croatia,
whereby for example complex ablation operations
would replace extensive local operations, significant
savings could be achieved because of the great dif-
ferences in the total costs of such therapeutic mod-
els (18.703 compared to 9.275 kn).
The study established that the complexity of
reconstruction significantly influences the cost of
treatment. Reconstruction with microvascular free
transplants is the most complex and expensive,
although there are studies which have shown that
the total cost of such reconstruction is lower than
the cost of reconstruction of pectoralis major by a
flap, because of the shorter treatment (13 compared
to 20 days) (11,12) and less complications (23 com-
pared to 50%) (13). In the present study we were
unable to prove the financial benefit of reconstruc-
tion by free transplants. The basis reasons being the
significant differences in the total costs of treatment
for patients in whom reconstruction was performed
by free transplants and pectoralis major flaps (43,060
compared to 24,161 kn), i.e. differences in the dura-
tion of treatment (70.5 compared to 50.2 days),
which raises the question of the adequate selection
and preparation of the patient. The study raises
numerous professional, medical and ethical ques-
tions, which are difficult to answer without investi-
gation of a larger sample, which would include not
only oncological and economic parameters, but also
psychological and sociological elements, which
would show the justification and cost-effectiveness
of reconstruction with free transplants. The duration
of treatment, and selection of the therapeutic process,
which includes the type of ablation and reconstruc-
tive operation, are directly dependent on the physi-
cian's decision, and raises the question of the respon-
sibility of the physician to plan the therapeutic pro-
cedure which would be both medically and eco-
nomically justified.
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Conclusions
• Share of hospital costs is high and amount to over
75% of the total treatment cost for the patient
with head and neck tumours.
• The duration of hospital treatment has a power-
ful influence on the cost of treatment and it is
possible to have an effect on it in all phases of
treatment.
• Increased complexity of ablation and recon-
structive operation has an effect on increased
treatment costs.
• The influence of the physician on the duration of
treatment and selection of therapy indicates the
need for their more active participation in the
planning of high quality and economically jus-
tified treatment.
